These results suggest that activation of AMBRA1 by disruption of the AMBRA1/DLC1 interaction may help promote the reactivation of quiescent NSCs, a major roadblock to sustain adult neurogenesis in neurodegenerative diseases. Here, DLC1 is linked to neurodegenerative disease.